← Back to Search

Stepped Care for Heart & Lung Rehabilitation

N/A
Recruiting
Research Sponsored by Peter Lindenauer, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has a condition qualifying for reimbursement (by government or private insurance) for cardiac or pulmonary rehabilitation
Score of 4, 5 or 6 on the Clinical Frailty Scale(24) (corresponding to vulnerable, mildly frail, and moderately frail)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial will focus on older adults who are candidates for cardiac or pulmonary rehabilitation and who are vulnerable, mildly or moderately frail. The goal is to see if stepped care, which includes traditional center-based rehabilitation as well as transportation-subsidized CBR, home-based telerehabilitation, and community health worker-supported home-based telerehabilitation, is more effective than treatment as usual.

Who is the study for?
This trial is for older adults aged 60+ living in rural areas of Berkshire County who have heart or lung conditions eligible for rehabilitation coverage. They should be mildly to moderately frail but not have severe medical issues like uncontrolled diabetes, recent cardiac rehab, or life-threatening arrhythmias.Check my eligibility
What is being tested?
The study compares traditional center-based rehabilitation (CBR) with a 'Stepped Care' approach that includes CBR and may add transportation subsidies, home-based telerehabilitation (TR), and community health worker support based on patient needs.See study design
What are the potential side effects?
Since the interventions involve different forms of rehabilitation care rather than medication, side effects are minimal but could include typical exercise-related risks such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My heart or lung condition is covered for rehab by insurance.
Select...
I am considered vulnerable to moderately frail according to the Clinical Frailty Scale.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Burden of Data Collection
Recruitment
+1 more
Secondary outcome measures
6 Minute walk test (6-MWT)
EuroQol (EQ-5D-5L)
PASE
+8 more
Other outcome measures
Secondary Feasibility Outcomes

Trial Design

2Treatment groups
Active Control
Group I: Treatment as usualActive Control1 Intervention
Patients referred to CR or PR are initially telephoned by a RN,RC or RA who describes the program and schedules the initial intake evaluation. The intake evaluation reflects usual care practices at both BMC and Fairview Hospital. The purpose of this initial session is to obtain the data required to design an individualized effective and safe rehabilitation program. It is performed by a RN, RC, or RA and includes performing a medical history, physical examination, and testing. Reminder telephone calls are placed prior to the initial intake and formal reassessments visits.
Group II: Stepped CareActive Control1 Intervention
The SC arm will be offered Center Based Rehabilitation (CBR) and subsequently stepped up to transportation-subsidized CBR, home-based TR, and CHW-supported home-based TR based on prespecified non-response criteria/poor adherence. Standard of Care. Patients meeting a non-response criterion will be stepped up to transportation-subsidized CBR. Step 1. Transportation-Subsidized CBR. Step 2. Home-Based TR. Step 3. CHW-Supported Home-Based TR.

Find a Location

Who is running the clinical trial?

Peter Lindenauer, MDLead Sponsor
Berkshire Medical CenterOTHER
1 Previous Clinical Trials
1,288 Total Patients Enrolled

Media Library

Stepped Care Clinical Trial Eligibility Overview. Trial Name: NCT05562037 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Treatment as usual, Stepped Care
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Stepped Care Highlights & Side Effects. Trial Name: NCT05562037 — N/A
Stepped Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05562037 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being recruited for this research experiment?

"Indeed, clinicaltrials.gov has documented that this medical experiment is actively recruiting participants; the trial was posted on September 8th 2022 and last modified on October 19th 2022. Two sites are looking to enrol 120 patients."

Answered by AI

Are there opportunities available for individuals to participate in this scientific experiment?

"Confirmed by clinicaltrials.gov, this study is presently recruiting participants for the trial that began on September 8th 2022 and was most recently modified on October 19th 2022."

Answered by AI

What is the primary focus of this exploration?

"This long-term clinical trial seeks to measure Adherence as its primary outcome after a duration of three years. Secondary goals include quantifying Smoking via self-reported data, and utilizing NIH PROMIS CAT scales to evaluate Social Isolation and Depression/Sadness."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I've been struggling with th I s for a few years and nothing has helped. I keep going down the rabbit hole.
PatientReceived 1 prior treatment
~36 spots leftby Dec 2024